• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy.糖尿病肾病中的肾小球20-羟基二十碳四烯酸、环氧二十碳三烯酸和转化生长因子-β1
Am J Physiol Renal Physiol. 2009 Mar;296(3):F556-63. doi: 10.1152/ajprenal.90613.2008. Epub 2009 Jan 7.
2
Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier.20-羟基二十碳四烯酸(20-HETE)对肾小球蛋白质通透屏障的保护作用
Kidney Int. 2005 Jan;67(1):152-6. doi: 10.1111/j.1523-1755.2005.00065.x.
3
Effect of Alpina oxyphylla extract on streptozotocin-induced kidney injure via regulating TGF-β1 and MyD88.阿尔卑斯唐松草提取物通过调节 TGF-β1 和 MyD88 对链脲佐菌素诱导的肾损伤的影响。
BMC Complement Med Ther. 2020 Jul 13;20(1):217. doi: 10.1186/s12906-020-02972-x.
4
Activation of 20-HETE/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy.柚皮素通过激活 20-HETE/PPARs 发挥肾脏保护作用治疗糖尿病肾病。
Chem Biol Interact. 2019 Jul 1;307:116-124. doi: 10.1016/j.cbi.2019.05.004. Epub 2019 May 4.
5
Transforming growth factor-beta, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats.转化生长因子-β、20-羟基二十碳四烯酸相互作用与 Dahl 盐敏感大鼠的肾小球损伤
Hypertension. 2005 Apr;45(4):643-8. doi: 10.1161/01.HYP.0000153791.89776.43. Epub 2005 Feb 21.
6
Triptolide Improves Renal Injury in Diabetic Nephropathy Rats through TGF-β1/Smads Signal Pathway.雷公藤内酯醇通过 TGF-β1/Smads 信号通路改善糖尿病肾病大鼠的肾损伤。
Endocr Metab Immune Disord Drug Targets. 2021;21(10):1905-1911. doi: 10.2174/1871530320666201208110209.
7
20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway.20-HETE 和 EETs 在糖尿病肾病中的作用:一种新的机制途径。
PLoS One. 2013 Aug 2;8(8):e70029. doi: 10.1371/journal.pone.0070029. Print 2013.
8
Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy.肾细胞色素 P450 和花生四烯酸代谢物在糖尿病肾病中的作用。
J Biol Regul Homeost Agents. 2013 Jul-Sep;27(3):693-703.
9
[Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].[选择性环氧化酶-2抑制剂对链脲佐菌素诱导的糖尿病大鼠肾脏病变的影响及其可能机制]
Zhonghua Yi Xue Za Zhi. 2002 Feb 25;82(4):239-43.
10
Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.螺内酯对链脲佐菌素诱导的糖尿病大鼠肾小球损伤的有益作用。
J Renin Angiotensin Aldosterone Syst. 2007 Sep;8(3):118-26. doi: 10.3317/jraas.2007.014.

引用本文的文献

1
A sensitive LC-MS/MS method for the quantification of serum epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in the identification of diabetic kidney disease.一种用于定量血清环氧二十碳三烯酸和二羟基二十碳三烯酸以鉴定糖尿病肾病的灵敏液相色谱-串联质谱法。
Anal Bioanal Chem. 2025 May;417(11):2193-2206. doi: 10.1007/s00216-025-05798-z. Epub 2025 Feb 20.
2
Identification of co-expressed central genes and transcription factors in acute myocardial infarction and diabetic nephropathy.鉴定急性心肌梗死和糖尿病肾病中的共表达中枢基因和转录因子。
BMC Med Genomics. 2024 May 20;17(1):134. doi: 10.1186/s12920-024-01906-7.
3
Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition.花生四烯酸代谢作为急性肾损伤向慢性肾脏病转变的治疗靶点。
Front Pharmacol. 2024 Mar 8;15:1365802. doi: 10.3389/fphar.2024.1365802. eCollection 2024.
4
Crocin Ameliorates Diabetic Nephropathy through Regulating Metabolism, CYP4A11/PPARγ, and TGF-β/Smad Pathways in Mice.藏红花酸通过调节代谢、CYP4A11/PPARγ 和 TGF-β/Smad 通路改善糖尿病肾病小鼠模型。
Curr Drug Metab. 2023;24(10):709-722. doi: 10.2174/0113892002257928231031113337.
5
SGLT2 Inhibitor-Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism.钠-葡萄糖协同转运蛋白2抑制剂达格列净通过CYP4A/20-羟基二十碳四烯酸信号机制调节炎症,减轻糖尿病诱导的肾损伤。
Pharmaceutics. 2023 Mar 16;15(3):965. doi: 10.3390/pharmaceutics15030965.
6
The CYP/20-HETE/GPR75 axis in hypertension.高血压中的 CYP/20-HETE/GPR75 轴。
Adv Pharmacol. 2022;94:1-25. doi: 10.1016/bs.apha.2022.02.003. Epub 2022 Mar 30.
7
Glomerular Biomechanical Stress and Lipid Mediators during Cellular Changes Leading to Chronic Kidney Disease.导致慢性肾病的细胞变化过程中的肾小球生物力学应激与脂质介质
Biomedicines. 2022 Feb 9;10(2):407. doi: 10.3390/biomedicines10020407.
8
Genetics Variants in the Epoxygenase Pathway of Arachidonic Metabolism Are Associated with Eicosanoids Levels and the Risk of Diabetic Nephropathy.花生四烯酸代谢环氧合酶途径中的基因变异与类二十烷酸水平及糖尿病肾病风险相关。
J Clin Med. 2021 Sep 2;10(17):3980. doi: 10.3390/jcm10173980.
9
Plasma and urinary concentrations of arachidonic acid-derived eicosanoids are associated with diabetic kidney disease.血浆和尿液中花生四烯酸衍生的类二十烷酸浓度与糖尿病肾病相关。
EXCLI J. 2021 Mar 18;20:698-708. doi: 10.17179/excli2021-3408. eCollection 2021.
10
The Human Genetic Variants CYP2J2 rs2280275 and EPHX2 rs751141 and Risk of Diabetic Nephropathy in Egyptian Type 2 Diabetic Patients.人类基因变体CYP2J2 rs2280275和EPHX2 rs751141与埃及2型糖尿病患者糖尿病肾病风险
Appl Clin Genet. 2020 Nov 19;13:165-178. doi: 10.2147/TACG.S281502. eCollection 2020.

本文引用的文献

1
Molecular mechanisms of diabetic nephropathy and its therapeutic intervention.糖尿病肾病的分子机制及其治疗干预
Curr Drug Targets. 2007 Aug;8(8):952-9. doi: 10.2174/138945007781386884.
2
Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier.花生四烯酸的内源性细胞色素P450代谢产物在维持肾小球蛋白质通透屏障中的作用。
Am J Physiol Renal Physiol. 2007 Aug;293(2):F501-5. doi: 10.1152/ajprenal.00131.2007. Epub 2007 May 16.
3
Increasing or stabilizing renal epoxyeicosatrienoic acid production attenuates abnormal renal function and hypertension in obese rats.增加或稳定肾脏环氧二十碳三烯酸的生成可减轻肥胖大鼠的肾功能异常和高血压。
Am J Physiol Renal Physiol. 2007 Jul;293(1):F342-9. doi: 10.1152/ajprenal.00004.2007. Epub 2007 Apr 18.
4
Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment.糖尿病肾病中转化生长因子β的调控:对治疗的启示
Semin Nephrol. 2007 Mar;27(2):153-60. doi: 10.1016/j.semnephrol.2007.01.008.
5
Eicosanoids and renal vascular function in diseases.疾病中的类二十烷酸与肾血管功能
Clin Sci (Lond). 2006 Jul;111(1):21-34. doi: 10.1042/CS20050251.
6
PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice.过氧化物酶体增殖物激活受体α激动剂非诺贝特可改善db/db小鼠的糖尿病肾病。
Kidney Int. 2006 May;69(9):1511-7. doi: 10.1038/sj.ki.5000209.
7
Renoprotective effects of fenofibrate in diabetic rats are achieved by suppressing kidney plasminogen activator inhibitor-1.非诺贝特通过抑制肾脏纤溶酶原激活物抑制剂-1对糖尿病大鼠产生肾脏保护作用。
Vascul Pharmacol. 2006 May;44(5):309-15. doi: 10.1016/j.vph.2006.01.004. Epub 2006 Apr 19.
8
Induction of renal 20-hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet-induced hypertension in rats.氯贝丁酯诱导大鼠肾脏产生20-羟基二十碳四烯酸可减轻高脂饮食诱导的高血压。
J Pharmacol Exp Ther. 2006 Apr;317(1):11-8. doi: 10.1124/jpet.105.095356. Epub 2005 Dec 8.
9
Kidney involvement in a nongenetic rat model of type 2 diabetes.2型糖尿病非基因大鼠模型中的肾脏受累情况
Kidney Int. 2005 Dec;68(6):2562-71. doi: 10.1111/j.1523-1755.2005.00727.x.
10
Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases.环氧水解酶和环氧合酶代谢产物作为肾脏疾病的治疗靶点。
Am J Physiol Renal Physiol. 2005 Sep;289(3):F496-503. doi: 10.1152/ajprenal.00350.2004.

糖尿病肾病中的肾小球20-羟基二十碳四烯酸、环氧二十碳三烯酸和转化生长因子-β1

Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy.

作者信息

Luo Pengcheng, Zhou Yiqiang, Chang Hsin-Hsin, Zhang Jie, Seki Tsugio, Wang Cong-Yi, Inscho Edward W, Wang Mong-Heng

机构信息

Department of Physiology, Medical College of Georgia, Augusta, Georgia 30912, USA.

出版信息

Am J Physiol Renal Physiol. 2009 Mar;296(3):F556-63. doi: 10.1152/ajprenal.90613.2008. Epub 2009 Jan 7.

DOI:10.1152/ajprenal.90613.2008
PMID:19129258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2660192/
Abstract

The early stage of diabetic nephropathy (DN) is linked to proteinuria. Transforming growth factor (TGF)-beta1 increases glomerular permeability to albumin (P(alb)), whereas 20-HETE and EETs reduce P(alb). To investigate the impact of hyperglycemia and hyperlipidemia on 20-HETE, EETs, and TGF-beta1 in the glomeruli, rats were divided into four groups: ND rats were fed a normal diet, HF rats were fed a high-fat diet, STZ rats were treated with 35 mg/kg of streptozotocin, and HF/STZ rats were fed a HF diet and treated with STZ. After 10 wk on these regimens, blood glucose, urinary albumin, serum cholesterol, serum triglyceride levels, and the kidney-to-body weight ratio were significantly elevated in STZ and HF/STZ rats compared with HF and ND rats. STZ and HF/STZ rats had histopathologic changes and abnormal renal hemodynamics. Expression of glomerular CYP4A, enzymes for 20-HETE production, was significantly decreased in STZ rats, whereas expression of glomerular CYP2C and CYP2J, enzymes for EETs production, was significantly decreased in both STZ and HF/STZ rats. Moreover, glomerular TGF-beta1 levels were significantly greater in STZ and HF/STZ rats than in HF and ND rats. Five-week treatment of STZ rats with clofibrate induced glomerular CYP4A expression and 20-HETE production, but reduced glomerular TGF-beta1 and urinary protein excretion. These results demonstrate that hyperglycemia increases TGF-beta1 but decreases 20-HETE and EETs production in the glomeruli, changes that may be important in causing glomerular damage in the early stage of DN.

摘要

糖尿病肾病(DN)的早期阶段与蛋白尿有关。转化生长因子(TGF)-β1会增加肾小球对白蛋白的通透性(P(alb)),而20-羟基二十碳四烯酸(20-HETE)和环氧二十碳三烯酸(EETs)则会降低P(alb)。为了研究高血糖和高血脂对肾小球中20-HETE、EETs和TGF-β1的影响,将大鼠分为四组:正常饮食的正常饮食组(ND)大鼠、高脂饮食的高脂饮食组(HF)大鼠、接受35mg/kg链脲佐菌素治疗的链脲佐菌素组(STZ)大鼠以及高脂饮食并接受链脲佐菌素治疗的高脂/链脲佐菌素组(HF/STZ)大鼠。在这些方案实施10周后,与HF和ND大鼠相比,STZ和HF/STZ大鼠的血糖、尿白蛋白、血清胆固醇、血清甘油三酯水平以及肾重与体重比均显著升高。STZ和HF/STZ大鼠出现了组织病理学变化和异常的肾脏血流动力学。STZ大鼠中,用于产生20-HETE的肾小球细胞色素P450 4A(CYP4A)酶的表达显著降低,而在STZ和HF/STZ大鼠中,用于产生EETs的肾小球细胞色素P450 2C(CYP2C)和细胞色素P450 2J(CYP2J)酶的表达均显著降低。此外,STZ和HF/STZ大鼠的肾小球TGF-β1水平显著高于HF和ND大鼠。用氯贝丁酯对STZ大鼠进行为期五周的治疗,可诱导肾小球CYP4A表达和20-HETE产生,但可降低肾小球TGF-β1和尿蛋白排泄。这些结果表明,高血糖会增加肾小球中TGF-β1的含量,但会降低20-HETE和EETs的产生,这些变化可能在DN早期导致肾小球损伤方面具有重要意义。